ATP is a specific consulting company for development and marketing of Advanced Therapy Medicinal Products (ATMPs). We focus on cell and tissue therapies, in particular on stem cell application and tissue engineering.

ATP attends to your innovative approach from pre-clinic to market authorization by providing advice on legal regulatory, on strategic and operative planning for pre-clinic, clinical studies, and authorization applications. The ATP team has many-year experience in the development and translation of Advanced Therapy Medicinal Products. Furthermore, the ATP team is part of a large expert network.

ATP offers its service to scientists, large and small businesses, investors, institutes and public institutions, as well as international enterprises which develop and market ATMPs in Germany and in Europe.